Clinical Trial Information Request for Protocol 25-461 Title A Phase 2, single-arm, open-label study evaluating subcutaneous isatuximab, administered by an on-body delivery system, in combination with weekly carfilzomib and dexamethasone in adult patients with relapsed and/or refractory multiple myeloma (RRMM) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone